You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 10, May 27, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal

Alcohol, Acetaminophen, and Toxic Effects on the Liver

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Although we do not dispute the factual results of the recently published study by Kuffner et al,1 "Effect of Maximum Daily Doses of Acetaminophen on the Liver of Alcoholic Patients," the conclusions reached by the authors, as well as their recommendations concerning alcohol consumption and acetaminophen, are of great concern and might pose a potential public health hazard. It is well known that acetaminophen possesses a narrow therapeutic index, and the potential for hepatoxicity can vary greatly among individuals, depending upon the clinical environmental situation. For example, persons with chronic alcoholism or persons with low caloric intake could become glutathione deficient and as a result be potentially more susceptible to acetaminophen-related hepatotoxicity. While doubling the 4-g maximum daily therapeutic dose is known to cause liver injury, in some individuals predisposed to hepatotoxicity, the tolerable dose may actually be significantly lower.2-3

The investigators have examined the effect of the maximum daily . . . [Full Text of this Article]


RELATED ARTICLE

Effect of Maximal Daily Doses of Acetaminophen on the Liver of Alcoholic Patients: A Randomized, Double-blind, Placebo-Controlled Trial
Edwin K. Kuffner, Richard C. Dart, Gregory M. Bogdan, Robert E. Hill, Edmund Casper, and Lisa Darton
Arch Intern Med. 2001;161(18):2247-2252.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.